Torsten Steinmetzer

5.1k total citations · 1 hit paper
137 papers, 3.8k citations indexed

About

Torsten Steinmetzer is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Torsten Steinmetzer has authored 137 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 29 papers in Oncology and 29 papers in Hematology. Recurrent topics in Torsten Steinmetzer's work include Blood Coagulation and Thrombosis Mechanisms (25 papers), Protease and Inhibitor Mechanisms (23 papers) and Peptidase Inhibition and Analysis (23 papers). Torsten Steinmetzer is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (25 papers), Protease and Inhibitor Mechanisms (23 papers) and Peptidase Inhibition and Analysis (23 papers). Torsten Steinmetzer collaborates with scholars based in Germany, United States and Hungary. Torsten Steinmetzer's co-authors include Wolfgang Garten, Eva Böttcher‐Friebertshäuser, Jörg Stürzebecher, Kornelia Hardes, Frank Sielaff, Manuel E. Than, Markus Eickmann, Maya Hammami, Andrea Schweinitz and Oliver Pilgram and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Torsten Steinmetzer

134 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells

2020 598 citations Miriam Ruth Heindl, Hannah Limburg et al. Life Science Alliance profile →

Peers

Countries citing papers authored by Torsten Steinmetzer

Since Specialization

Citations

This map shows the geographic impact of Torsten Steinmetzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torsten Steinmetzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torsten Steinmetzer more than expected).

Fields of papers citing papers by Torsten Steinmetzer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torsten Steinmetzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torsten Steinmetzer. The network helps show where Torsten Steinmetzer may publish in the future.

Co-authorship network of co-authors of Torsten Steinmetzer

This figure shows the co-authorship network connecting the top 25 collaborators of Torsten Steinmetzer. A scholar is included among the top collaborators of Torsten Steinmetzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Torsten Steinmetzer. Torsten Steinmetzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design, Synthesis, and Characterization of Dichlorobiphenyl-Derived Inhibitors of the Proprotein Convertase Furin 2025 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), Eva Böttcher‐Friebertshäuser, Hans Brandstetter, Sven O. Dahms, Torsten Steinmetzer	0
2	In Vitro Evaluation of Antipseudomonal Activity and Safety Profile of Peptidomimetic Furin Inhibitors 2024 ·Biomedicines ·(unknown), (unknown), Miklós Poór, (unknown), Torsten Steinmetzer, Ákos Jerzsele, (unknown), Dávid Bajusz, Anita Rácz, (unknown)	0
3	Fragment‐Based Design, Synthesis, and Characterization of Aminoisoindole‐Derived Furin Inhibitors 2024 ·ChemMedChem ·(unknown), (unknown), Miriam Ruth Heindl, J. Wollenhaupt, M.S. Weiss, Hans Brandstetter, G. Klebe, Franco H. Falcone, Eva Böttcher‐Friebertshäuser, Sven O. Dahms, Torsten Steinmetzer	4
4	Synthesis and structural characterization of new macrocyclic inhibitors of the Zika virus NS2B–NS3 protease 2024 ·Archiv der Pharmazie ·(unknown), (unknown), (unknown), (unknown), Daniela Bender, Eberhard Hildt, A. Heine, Torsten Steinmetzer	2
5	Unveiling the Role of TMPRSS2 in the Proteolytic Activation of Pandemic and Zoonotic Influenza Viruses and Coronaviruses in Human Airway Cells 2024 ·Viruses ·(unknown), (unknown), (unknown), Hannah Limburg, Torsten Steinmetzer, David A. Stein, Hong M. Moulton, Eva Böttcher‐Friebertshäuser	1
6	Synthesis and Structural Characterization of Macrocyclic Plasmin Inhibitors 2023 ·ChemMedChem ·(unknown), Guojie Wu, (unknown), (unknown), (unknown), James C. Whisstock, Ruby H. P. Law, Torsten Steinmetzer	1
7	Interspecies Comparisons of the Effects of Potential Antiviral 3-Amidinophenylalanine Derivatives on Cytochrome P450 1A2 Isoenzyme 2022 ·Veterinary Sciences ·(unknown), (unknown), Gábor Nagy, (unknown), (unknown), (unknown), Zoltán Pászti, Ákos Jerzsele, Oliver Pilgram, Torsten Steinmetzer, Gábor Mátis, Zsuzsanna Neogrády, (unknown)	4
8	Boroleucine‐Derived Covalent Inhibitors of the ZIKV Protease 2022 ·ChemMedChem ·(unknown), (unknown), (unknown), A. Heine, Torsten Steinmetzer	6
9	How a Fragment Draws Attention to Selectivity Discriminating Features between the Related Proteases Trypsin and Thrombin 2021 ·Journal of Medicinal Chemistry ·(unknown), (unknown), J. Schiebel, (unknown), Linda C. Schmidt, (unknown), Torsten Steinmetzer, Andreas Ostermann, A. Heine, G. Klebe	1
10	The Basicity Makes the Difference: Improved Canavanine-Derived Inhibitors of the Proprotein Convertase Furin 2021 ·ACS Medicinal Chemistry Letters ·(unknown), Miriam Ruth Heindl, (unknown), Eva Böttcher‐Friebertshäuser, Ralf Bartenschlager, G. Klebe, Hans Brandstetter, Sven O. Dahms, Torsten Steinmetzer	19
11	TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells breakdown → 2020 ·Life Science Alliance ·(unknown), Miriam Ruth Heindl, Hannah Limburg, (unknown), Oliver Pilgram, Hong M. Moulton, David A. Stein, Kornelia Hardes, Markus Eickmann, Olga Dolnik, Cornelius Rohde, Hans-Dieter Klenk, Wolfgang Garten, Torsten Steinmetzer, Eva Böttcher‐Friebertshäuser	598
12	A novel cell‐based sensor detecting the activity of individual basic proprotein convertases 2019 ·FEBS Journal ·Karin Löw, Kornelia Hardes, Chiara Fedeli, Nabil G. Seidah, Daniel B. Constam, Antonella Pasquato, Torsten Steinmetzer, Alexandre Roulin, Stefan Kunz	4
13	Strategies for Late-Stage Optimization: Profiling Thermodynamics by Preorganization and Salt Bridge Shielding 2019 ·Journal of Medicinal Chemistry ·(unknown), T. Hüfner, A. Heine, Torsten Steinmetzer, G. Klebe	16
14	The Impact of Acute Matriptase Inhibition in Hepatic Inflammatory Models 2016 ·BioMed Research International ·(unknown), (unknown), (unknown), Gábor Mátis, Zsuzsanna Neogrády, Torsten Steinmetzer, (unknown)	8
15	Highly Potent Inhibitors of Proprotein Convertase Furin as Potential Drugs for Treatment of Infectious Diseases 2012 ·Journal of Biological Chemistry ·(unknown), Yinghui Lu, Kornelia Hardes, Boris Strehlow, Christine Levesque, Iris Lindberg, Kirsten Sandvig, Udo Bakowsky, Robert Day, Wolfgang Garten, Torsten Steinmetzer	93
16	New furin inhibitors based on weakly basic amidinohydrazones 2010 ·Bioorganic & Medicinal Chemistry Letters ·Frank Sielaff, Manuel E. Than, Dorian Bevec, Iris Lindberg, Torsten Steinmetzer	26
17	Progress in the Development of Synthetic Thrombin Inhibitors as New Orally Active Anticoagulants 2004 ·Current Medicinal Chemistry ·Torsten Steinmetzer, Jörg Stürzebecher	60
18	Influence of Structural Variations in Peptidomimetic 4-Amidinophenylalanine-Derived Thrombin Inhibitors on Plasma Clearance and Biliary Excretion in Rats 2002 ·Pharmaceutical Research ·Jörg Hauptmann, Torsten Steinmetzer, (unknown), P Wikström, Jörg Stürzebecher	10
19	Structure-Activity Relationships of New NAPAP-Analogs 2001 ·Journal of enzyme inhibition ·Torsten Steinmetzer, (unknown), (unknown), (unknown), Jörg Hauptmann, Jörg Stürzebecher	10
20	New Photoaffinity Labelled Agonists of Bradykinin 1995 ·Biological Chemistry Hoppe-Seyler ·Torsten Steinmetzer, C Schumann, I. Paegelow, Claus Liebmann, (unknown), D. Brandenburg, Siegmund Reißmann	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact